Global Trusted Preclinical Testing Provider

Accuprec Services – CPHI Frankfurt

Global Trusted Preclinical Testing Provider

Comprehensive Toxicological and Preclinical Testing Solutions for Drug Safety and Efficacy

Introduction

Preclinical testing plays a vital role in transforming new molecules into safe, effective medicines. At Accuprec Research Labs, we are committed to supporting pharmaceutical innovations with our comprehensive range of toxicological and preclinical testing services, helping our clients meet global regulatory requirements and bring safer drugs to market faster.

Why Preclinical Testing is Important

  • Establishes safety profiles before human trials
  • Identifies potential toxicity and adverse effects
  • Ensures compliance with GLP, OECD, and international standards
  • Provides critical data for regulatory submissions

Accuprec’s Capabilities

Our preclinical facility offers a wide range of GLP-compliant studies, including:

  • Acute, sub-acute, and chronic toxicity studies
  • Local tolerance and irritation studies
  • Genotoxicity and reproductive toxicity assessments
  • Safety pharmacology and dose-ranging studies
  • Toxicokinetic evaluations

Facilities & Expertise

Regulatory Compliance

Our preclinical studies align with the following regulatory frameworks:

  • OECD GLP Guidelines
  • FDA and EMA Preclinical Testing Requirements
  • Schedule Y (CDSCO India)

Meet Us at CPHI Frankfurt 2025

Join Accuprec at Stall D96 | Hall 6.1 at Messe Frankfurt, Germany, to explore our world-class toxicological and preclinical testing services that ensure global compliance and product safety.

#PreclinicalTesting #Toxicology #DrugSafety #GLP #AccuprecResearch #PharmaCompliance #CPHIFrankfurt2025
What do you think?
Insights

More Related Articles

QbD in Pharmaceutical Formulation: Why Building Quality In Is No Longer Optional

Extractables & Leachables Testing in 2026: The Compliance Gap Most Companies Miss

Elemental Impurities Under ICH Q3D: Why Your Risk Assessment May Not Be Enough